Skip to content

Atlas Bio raised $12.5 million in a seed round led by Creandum and First Momentum Ventures and LEA Partners, announced Oct. 27.

Facts

Company
Atlas Bio
Amount
$12.5 million
Currency
USD
Stage
Seed
Announced
Oct 27, 2026

Investors

Use of funds

Scale scientific and commercial teams, deepen platform validation, and onboard further enterprise clients through 2026.

As stated by the company.

Sources

  1. 1.Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing — Tech.eu, Oct 27, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 27, 2026